Cargando…
LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases
BACKGROUND: Live kinase B1 (LKB1) is a tumor suppressor that is mutated in Peutz-Jeghers syndrome (PJS) and a variety of cancers. Lkb1 encodes serine-threonine kinase (STK) 11 that activates AMP-activated protein kinase (AMPK) and its 13 superfamily members, regulating multiple biological processes,...
Autores principales: | Zhang, Yanghe, Meng, Qingfei, Sun, Qianhui, Xu, Zhi-Xiang, Zhou, Honglan, Wang, Yishu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753952/ https://www.ncbi.nlm.nih.gov/pubmed/33278637 http://dx.doi.org/10.1016/j.molmet.2020.101131 |
Ejemplares similares
-
Recent findings in the regulation of G6PD and its role in diseases
por: Meng, Qingfei, et al.
Publicado: (2022) -
The role of liver kinase B1 in tumor progression through regulation of lipid metabolism
por: Geng, Jialu, et al.
Publicado: (2022) -
Lipid and glucose metabolism in senescence
por: Liu, Bin, et al.
Publicado: (2023) -
Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress
por: Wang, Yishu, et al.
Publicado: (2019) -
Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1-deficient Kras-driven lung tumorigenesis
por: Bhatt, Vrushank, et al.
Publicado: (2019)